1. Armstrong, D., and Eckert, R., 1987, Voltage-activated calcium channels that must be phosphorylated to respond to membrane depolarization. Proc. Natl. Acad. Sci. USA 84: 2518–2522.
2. Bonvallet, S.T., Zamora, M.R., Hasunuma, K., Sato, K., Hanasato, N., Anderson, D., and Stelzner, T.J., 1994, BQ123, an ETA-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats. Am. J. Physiol. 266(35): H1327–H1331.
3. Chen, J., He, L., Dinger, B., and Fidone, S. (in press), Cellular mechanisms involved in rabbit carotid body excitation elicited by endothelin peptides. Resp. Physiol.
4. Chen, S.-J., Chen, Y.-F., Meng, Q.C., Durand, J., Dicarlo, V.S., and Oparil, S., 1995, Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J. Appl. Physiol. 79(6): 2122–2131.
5. Eddahibi, S., Springall, D., Mannan, M., Carville, C., Chabrier, P.-E., Levame, M., Raffestin, B., Polak, J., and Adnot, S., 1993, Dilator effect of endothelins in pulmonary circulation: chanes associated with chronic hypoxia. Am. J. Physiol. 265(9): L571–L580.